Oorsprong van het eerstegraads netwerk van Sylvia Tobe
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
JDRF T1D Fund
 JDRF T1D Fund Investment ManagersFinance JDRF T1D Fund (JDRF T1D Fund) is a venture capital subsidiary of JDRF International founded in 2011 by Sean Doherty. The firm is headquartered in Boston, Massachusetts.
22
| Subsidiary | Investment Managers | 22 |
Sorbonne Université
10
| College/University | Other Consumer Services | 10 |
Omega Fund Management LLC
 Omega Fund Management LLC Investment ManagersFinance Omega Fund Management Ltd. (OFM) is the wholly-owned private equity firm founded by Dr. Otello Stampacchia in 2004. The firm is headquartered in the US.
7
| Private Company | Investment Managers | 7 |
Joseph Fourier University
1
| College/University | Other Consumer Services | 1 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Sylvia Tobe via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| MERCK & CO., INC. | Pharmaceuticals: Major | Sales & Marketing | |
| TRIMAS CORPORATION | Miscellaneous Manufacturing | Chief Executive Officer | |
| AEGERION PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Executive Officer | |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA. | College/University | Corporate Officer/Principal Undergraduate Degree | |
Bain Capital LP
 Bain Capital LP Financial ConglomeratesFinance Bain Capital LP engages in provision of investment consulting services. It specializes in private equity, credit, public equity, venture, real estate, double impact, life sciences, and partnership strategies. The company was founded in 1984 and is headquartered in Boston, MA. | Financial Conglomerates | General Counsel | |
| THE MONKS INVESTMENT TRUST PLC | Investment Trusts/Mutual Funds | Director/Board Member | |
| BLUEBIRD BIO, INC. | Biotechnology | Director/Board Member Director/Board Member | |
| University of Cambridge | College/University | Undergraduate Degree Undergraduate Degree | |
| Rutgers State University of New Jersey | College/University | Undergraduate Degree Doctorate Degree Undergraduate Degree | |
| The University of Chicago | College/University | Doctorate Degree Masters Business Admin | |
| Yale University | College/University | Undergraduate Degree Doctorate Degree | |
| University of Kansas | College/University | Corporate Officer/Principal Undergraduate Degree | |
| University of Mississippi | College/University | Undergraduate Degree | |
American Academy of Pediatrics
 American Academy of Pediatrics Medical/Nursing ServicesHealth Services American Academy of Pediatrics operates as a professional association of pediatricians to the optimal physical, mental, and social health and well-being for all infants, children, adolescents, and young adults. The company was founded on June 23, 1930 and is headquartered in Elk Grove Village, IL. | Medical/Nursing Services | Corporate Officer/Principal | |
| NeoMed S.à.r.l. | Investment Managers | Private Equity Investor | |
| US Department of the Navy (District of Columbia) | Sovereign | Corporate Officer/Principal | |
JDRF International
 JDRF International Miscellaneous Commercial ServicesCommercial Services JDRF International is a leader in setting the agenda for diabetes research worldwide, and is the largest charitable funder of and advocate for type 1 diabetes research. JDRF find a cure for diabetes and its complications through the support of research. Type 1 diabetes is an autoimmune disease that strikes children and adults suddenly, and can be fatal. Until a cure is found, people with type 1 diabetes have to test their blood sugar and give themselves insulin injections multiple times or use a pump each day, every day of their lives. And even with that intensive care, insulin is not a cure for diabetes, nor does it prevent its potential complications, which may include kidney failure, blindness, heart disease, stroke, and amputation. It was founded in 1970 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Chairman Director/Board Member Chairman Director/Board Member Chief Executive Officer Director/Board Member Director/Board Member | |
Neomed Management (Jersey) Ltd.
 Neomed Management (Jersey) Ltd. Investment ManagersFinance Neomed Management (Jersey) Ltd. is an investment firm invests in innovative healthcare and life science companies. The company is headquartered in St. Helier, the United Kingdom. | Investment Managers | Corporate Officer/Principal | |
OrbiMed Advisors Private Equity
 OrbiMed Advisors Private Equity Investment ManagersFinance OrbiMed Advisors Private Equity (OrbiMed Advisors Private Equity) is a private equity and venture capital subsidiary of Orbimed Advisors LLC founded in 1993 by Samuel D. Isaly. The firm is headquartered in New York and it has additional offices in San Francisco, Mumbai, Shanghai, Herzliya, Hong Kong and London. | Investment Managers | Private Equity Investor | |
Trustees of Thayer Academy
 Trustees of Thayer Academy Miscellaneous Commercial ServicesCommercial Services The Thayer Academy provides educational services. It regulates student enrollment requirements and establishes educational standards, procedures, and curriculum. The firm offers college preparatory education that attracts students from diverse social, ethnic, economic, and academic backgrounds. The company was founded in 1877 and is headquartered in Braintree, MA. | Miscellaneous Commercial Services | Director/Board Member | |
Thermalin, Inc.
 Thermalin, Inc. Pharmaceuticals: MajorHealth Technology Thermalin, Inc. engages in the development of insulin products for patients with diabetes. It offers stabilized, ultra-rapid, and highly concentrated; no refrigeration basal and mix; glucose-responsive smart basal; and StampPump insulins. The company was founded by Michael A. Weiss, Bruce H. Frank, and Richard Berenson in 2010 and is headquartered in Cleveland, OH. | Pharmaceuticals: Major | Director/Board Member | |
| A.B. Freeman School of Business | College/University | Masters Business Admin Masters Business Admin | |
TopiVert Ltd.
 TopiVert Ltd. BiotechnologyHealth Technology TopiVert Ltd. develops topical treatments for inflammatory diseases of the eye and gut. Its application is used in the treatment of asthma, chronic obstructive pulmonary disease, and cystic fibrosis and other inflammatory diseases of the lungs. The company was founded by Eric Charles Meldrum in 2011 and is headquartered in London, the United Kingdom. | Biotechnology | Director/Board Member | |
Ropes & Gray LLP
 Ropes & Gray LLP Miscellaneous Commercial ServicesCommercial Services Ropes & Gray LLP provides legal and private equity services. Its practice areas include asset management, banking, business and commercial litigation, business restructuring, capital markets and corporate governance and compliance. The company was founded in 1865 and is headquartered in Boston, MA. | Miscellaneous Commercial Services | General Counsel | |
Topivert Pharma Ltd.
 Topivert Pharma Ltd. Pharmaceuticals: MajorHealth Technology Topivert Pharma Ltd. is a British pharmaceutical company founded in 2011. The private company develops non-systemic medicines for the treatment of chronic inflammatory diseases of the gastrointestinal. | Pharmaceuticals: Major | Director/Board Member | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin | |
| Harvard Business School | College/University | Masters Business Admin Graduate Degree | |
| Harvard Law School | College/University | Graduate Degree | |
| Harvard College | College/University | Undergraduate Degree | |
| WILSON THERAPEUTICS AB | Pharmaceuticals: Major | Director/Board Member | |
| IMAGO BIOSCIENCES, INC. | Biotechnology | Director/Board Member | |
ImmunoMolecular Therapeutics, Inc.
 ImmunoMolecular Therapeutics, Inc. BiotechnologyHealth Technology ImmunoMolecular Therapeutics LLC develops and manufactures immuno-therapeutic drugs for autoimmune diseases. The firm offers oral small molecule that starves the autoimmune process in type 1 diabetes by blocking DQ8 on specific immune cells. The company was founded by Steve Orndorff, Aaron Michels, and Peter Gottlieb in 2015 and is headquartered in Broomfield, CO. | Biotechnology | Director/Board Member | |
Oxular Ltd.
 Oxular Ltd. BiotechnologyHealth Technology Oxular Ltd. engages in research and experimental development on biotechnology. The firm develops retinal treatments to access specific small spaces in the eye and to provide drug distribution to tissues involved in retinal diseases. The company was founded by Tom Cavanagh and Ronald K. Yamamoto in 2014 and is headquartered in Oxford, the United Kingdom. | Biotechnology | Director/Board Member | |
Attenua, Inc.
 Attenua, Inc. Pharmaceuticals: MajorHealth Technology Attenua, Inc. engages in the provision of biopharmaceutical services. The company was founded by Jing Liang and is headquartered in San Mateo, CA. | Pharmaceuticals: Major | Director/Board Member | |
| PROVENTION BIO, INC. | Pharmaceuticals: Major | Director/Board Member | |
BC XII Private Investors (Lux) SCSP
 BC XII Private Investors (Lux) SCSP Investment ManagersFinance BC XII Private Investors (Lux), SCSp operates as private equity fund. The company is headquartered in Findel, Luxembourg. | Investment Managers | Chief Executive Officer | |
| SPRUCE BIOSCIENCES, INC. | Biotechnology | Director/Board Member | |
IFM Cinque, Inc.
 IFM Cinque, Inc. Miscellaneous Commercial ServicesCommercial Services IFM Cinque, Inc. is a biotechnology company. The company is headquartered in Boston, MA. | Miscellaneous Commercial Services | Director/Board Member | |
IFM Continua, Inc.
 IFM Continua, Inc. BiotechnologyHealth Technology IFM Continua, Inc. engages in the provision of biotechnology services. The company is headquartered in Boston, MA. | Biotechnology | Director/Board Member | |
IFM Quattro, Inc.
 IFM Quattro, Inc. Miscellaneous Commercial ServicesCommercial Services IFM Quattro, Inc. is a biotechnology company. The company is headquartered in Boston, MA. | Miscellaneous Commercial Services | Director/Board Member | |
| Oxular Acquisitions Ltd. | Director/Board Member | ||
Anjarium Biosciences AG
 Anjarium Biosciences AG BiotechnologyHealth Technology Anjarium Biosciences AG is a Swiss company that focuses on creating a new class of non-viral gene therapies to tackle genetic diseases throughout a patient's lifetime. The company is based in Schlieren, Switzerland. The company's versatile platform leverages breakthrough science and expertise at the interface of genetic medicine, synthetic biology, and nanoparticle engineering to generate a pipeline of advanced gene therapies with unique competitive advantages over current viral-vector based gene therapies. Anjarium's investors include leading international and strategic investors such as Abingworth, Gimv, Omega Funds, Pfizer Ventures, and Surveyor Capital. The company was founded by Joël de Beer, and Stephen Yoo has been the CEO of the company since 2022. | Biotechnology | Director/Board Member | |
Invest Europe
 Invest Europe Investment ManagersFinance Invest Europe is a Belgian company that operates as a private equity, venture capital and infrastructure investment company. The company is based in Brussels, Belgium. | Investment Managers | Director/Board Member | |
Aerium Therapeutics, Inc.
 Aerium Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Aerium Therapeutics, Inc. is an American biotechnology company that focuses on epidemic and pandemic preparedness. The company is based in Lausanne and has operations in the United States. The company's mission is to discover and develop antibodies and small molecule antivirals against SARS-CoV-2 and other epidemic and pandemic threats. Aerium Therapeutics has a team of world-class scientists and biotechnology veterans, as well as experienced investors. Aerium's lead assets are monoclonal antibodies that show broad activity against important variants of concern (VOCs) of SARS-CoV-2, including Omicron and its subvariants. The company plans to expand its pipeline to antiviral therapeutics in late 2022 and will broaden its focus to other epidemic and pandemic threats in the future. The CEO of the company is Rajeev Venkayya. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| Orbimed Advisors Private Equity/UK/ | Investment Managers | Private Equity Investor | |
| JDRF New England Chapter | President |
Statistieken
Internationaal
| Verenigde Staten | 33 |
| Verenigd Koninkrijk | 10 |
| Zwitserland | 4 |
| Frankrijk | 3 |
| China | 2 |
Sectoraal
| Health Technology | 18 |
| Consumer Services | 14 |
| Finance | 9 |
| Commercial Services | 7 |
| Producer Manufacturing | 2 |
Operationeel
| Director/Board Member | 166 |
| Private Equity Investor | 50 |
| Corporate Officer/Principal | 47 |
| Chairman | 33 |
| Undergraduate Degree | 30 |
Sterkste connecties
| Insiders | |
|---|---|
| Michael Powell | 48 |
| John Maraganore | 38 |
| Steven St. Peter | 26 |
| Dina Chaya | 23 |
| Grant Beard | 21 |
| Paul B. Queally | 20 |
| Brady Bohrmann | 19 |
| Stephen L. Newman | 18 |
| Francine Kaufman | 15 |
| Roshawn Blunt | 14 |
| Sean N. Doherty | 12 |
| Katie Ellias | 11 |
| Douglas A. Melton | 11 |
| Gerald L. Wisler | 9 |
| Karen Jordan | 8 |
- Beurs
- Insiders
- Sylvia Tobe
- Bedrijfsconnecties
